Riskpilot← Back to searchSign inGet full accessPromeduc Surgical AB
ABActiveOrg 5562797125Rubanksgatan 8Other human health activities n.e.c. · NACE 8699Est. 19867 employees
Revenue 2025
SEK 94,2M
+19% vs 2024
EBITDA margin
29.7%
+3% vs 2024
Equity ratio
48.7%
Financial strength
Net profit 2025
SEK 21,1M
-3% vs 2024
| Revenue | SEK 94,2M | +19% |
| EBITDA | SEK 28M | +3% |
| Net profit | SEK 21,1M | -3% |
| Total assets | SEK 91M | +26% |
| Equity | SEK 44,3M | +91% |
| Employees | 7 | — |
Legal name
Promeduc Surgical AB
Org number
5562797125
Legal form
Aktiebolag
NACE code
8699 · Other human health activities n.e.c.
Founded
16 juni 1986
Share capital
SEK 100 000
Employees
7 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget skall förvalta fast och lös egendom, bedriva konsultverksamhet, försälja varor och handha agenturer inom sjukvård samt därmed förenlig verksamhet.
Address
Rubanksgatan 8
Email
promeduc@promeduc.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 70 031 | 81 263 | 86 338 | 79 188 | 94 247 |
| Staff expenses | — | −8 587 | — | — | −6 928 |
| EBITDA | 23 619 | 22 469 | 26 596 | 27 099 | 28 014 |
| Depreciation & amort. | −872 | −872 | −485 | −353 | −380 |
| EBIT | 22 747 | 21 597 | 26 111 | 26 746 | 27 634 |
| Net financials | −244 | 126 | 92 | 1 467 | 530 |
| Profit before tax | 22 503 | 21 723 | 13 702 | 27 348 | 26 664 |
| Tax | −4 821 | −4 497 | −2 836 | −5 671 | −5 529 |
| Net profit | 17 682 | 17 226 | 10 866 | 21 677 | 21 134 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 46 820 | 51 363 | 52 096 | 72 198 | 90 993 |
| Equity | 20 414 | 17 639 | 11 506 | 23 183 | 44 317 |
| Long-term debt | 0 | — | 0 | 0 | — |
| Short-term debt | 26 406 | 33 723 | 40 590 | 49 015 | 46 676 |
| Total debt | 26 406 | 33 723 | 40 590 | 49 015 | 46 676 |
EBITDA margin
29.7%
This company
15.8%
Market median
+88% vs market
20212025
Equity ratio
48.7%
This company
38.2%
Market median
+27% vs market
20212025
Return on equity
47.7%
This company
18.4%
Market median
+159% vs market
20212025
Net profit margin
22.4%
This company
8.1%
Market median
+177% vs market
20212025
Asset turnover
1.04×
This company
1.12×
Market median
+7% vs market
20212025
Debt / equity
1.05×
This company
0.62×
Market median
-69% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
PA Chief Executive Officer | Chief Executive Officer | 2022 |
MM | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Ecin Consult AB
Promeduc Surgical AB Board members of Promeduc Surgical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Philip Anaxes | Chief Executive Officer | 0 companies |
| Magnus Mats Johan Hedin | Audit | 0 companies |
| Pontus Sven Henrik Forsberg | Deputy Board Member | 0 companies |
| Urban Carl Fredrik Forsberg | Board of Directors | 0 companies |